Viewing StudyNCT00390221



Ignite Creation Date: 2024-05-05 @ 5:07 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00390221
Status: COMPLETED
Last Update Posted: 2016-07-11
First Post: 2006-10-17

Brief Title: Safety and Efficacy Study of Daclizumab High Yield Process DAC HYP to Treat Relapsing-Remitting Multiple Sclerosis
Sponsor: Biogen
Organization: Biogen

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-02
Start Date Type: None
Primary Completion Date: 2011-05
Primary Completion Date Type: ACTUAL
Completion Date: 2011-08
Completion Date Type: ACTUAL
First Submit Date: 2006-10-17
First Submit QC Date: October 18 2006
Study First Post Date: 2006-10-19
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2016-07-11
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2014-10-13
Disp First Submit QC Date: October 13 2014
Disp First Post Date: 2014-10-22
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2016-05-31
Last Update Post Date: 2016-07-11
Last Update Post Date Type: ESTIMATED